Dasatinib: A Review of its Use in the Treatment of Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia

Author： McCormack Paul L.   Keam Susan J.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.13, 2011-09, pp. : 1771-1795

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dasatinib for the treatment of Philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure

By Hochhaus Andreas  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 18, 2007-12 ,pp. : 3257-3264

Informa Healthcare

Access to resources Recommend Favorite

Imatinib: In Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia

By Cross Sarah A.   Lyseng-Williamson Katherine A.  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2645-2654

Adis International

Access to resources Recommend Favorite

Nilotinib: In the First-Line Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia in Chronic Phase

By Garnock-Jones Karly P.  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1579-1590

Adis International

Access to resources Recommend Favorite

Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: A Viewpoint by Joseph Brandwein

By Brandwein Joseph  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2655-2656

Adis International

Access to resources Recommend Favorite

Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review

By Kline Justin P   Larson Richard A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2711-2718

Informa Healthcare

Access to resources Recommend Favorite